About Febit
Febit is a company based in Wrocław (Poland) founded in 2005 was acquired by Synthetic Genomics in September 2012. Febit operates in a competitive market with competitors including Ansa Biotechnologies, Nuclera Nucleics, Twist Bioscience, GenMark Diagnostics and Stilla Technologies, among others.
- Headquarter Wrocław, Poland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Synthetic Genomics
& 1 more
-
Employee Count
Not available
-
Acquired by
Synthetic Genomics
(Sep 17, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Febit
Investors in Febit
Febit has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Synthetic Genomics and In-Q-Tel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm
|
Locked | Locked | Locked | |
|
Synthetic genomic solutions are provided for research and bioproduction markets.
|
Locked | Locked | Locked |
Investor details for Febit
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Febit
Investment portfolio details for Febit
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Febit
Detailed financials for Febit
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Febit Comparisons
Peer comparison for Febit
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Febit
Febit operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ansa Biotechnologies, Nuclera Nucleics, Twist Bioscience, GenMark Diagnostics and Stilla Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
DNA synthesis technology using enzymes is provided.
|
|
| Locked | Locked | Locked |
Desktop bioprinter for genes and proteins production is developed.
|
|
| Locked | Locked | Locked |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| Locked | Locked | Locked |
Digital PCR solutions for research are developed and analyzed.
|
|
| Locked | Locked | Locked |
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
|
Detailed competitors of Febit
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Febit
Complete news archive for Febit
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Febit
Febit was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Febit is headquartered in Wrocław, Poland. It is registered at Wrocław, Lower Silesian Voivodeship, Poland.
Febit was founded in 2005 and is based in Wroclaw, Poland. Operations focus on the biotechnology sector, where the geniom platform and related services are delivered to support researchers in genomic studies. The Geniom Biochip is offered as a complete, ready-to-use solution for microarray analysis devices, enabling simplified control and execution of genomic research tasks.
Febit's top competitors include Nuclera Nucleics, GenMark Diagnostics and Stilla Technologies.
Febit has 2 investors. Key investors include Synthetic Genomics, and In-Q-Tel.